An oncolytic vaccinia virus expressing anti-CD47 nanobody exerts enhanced antitumor activity by mediating innate and adaptive immune cell infiltration and activation in the lymphoma tumor microenvironment. [PDF]
Li M +6 more
europepmc +1 more source
A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer. [PDF]
Chen L +15 more
europepmc +1 more source
Oncolytic vaccinia virus armed with anti-CD47 nanobody elicit potent antitumor effects on multiple tumor models via enhancing innate and adoptive immunity. [PDF]
Li Z +6 more
europepmc +1 more source
ROS Induced by Aphrocallistes vastus Lectin Enhance Oncolytic Vaccinia Virus Replication and Induce Apoptosis in Hepatocellular Carcinoma Cells. [PDF]
Zhang Y +8 more
europepmc +1 more source
GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer. [PDF]
Xuan Y +13 more
europepmc +1 more source
Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus. [PDF]
Zhou D +11 more
europepmc +1 more source
An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy. [PDF]
Wang S, Li Y, Xu C, Dong J, Wei J.
europepmc +1 more source
AVL-armed oncolytic vaccinia virus promotes viral replication and boosts antitumor immunity via increasing ROS levels in pancreatic cancer. [PDF]
Yu J +8 more
europepmc +1 more source
Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models. [PDF]
Umer BA +8 more
europepmc +1 more source

